Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-30 @ 11:07 PM
Study NCT ID:
NCT07177105
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-16
First Post:
2025-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC
Sponsor:
Jianxing He
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ES-2025-159-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None